INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

74,050 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$336K
11.9K sh
Oct 29, 2026
Page 198 of 1852
← PrevNext →
Oct 29, 2026
traded Oct 29, 2026
+0d
SEC Form 4

Evidence

4
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
6,000 sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

4
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
3,462 sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

3
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$32K
200 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

3
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$48K
300 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

3
TJ
Twomey Christopher JDirector
TNDMTANDEM DIABETES CARE INC
Option exercise · 10b5-1 plan
M$32K
1,700 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

3
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$80K
3,000 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$244K
8,881 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
403.4K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$17K
100 sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$4,725
189 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 29, 2026Oct 29, 2026
traded Oct 29, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
BM
Buczkowski MichelleChief Commercial Officer
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
TJ
Twomey Christopher JDirector
TNDMTANDEM DIABETES CARE INC
Option exercise · 10b5-1 plan
M—
1,700 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
12.0K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 29, 2026Oct 29, 2026
traded Oct 29, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5,780
200 sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
12.0K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC Form 4

Evidence

56
PK
Polito KarynDirector
BBTBeacon Financial Corp
Open-market purchase
BUY$31K
1,000 sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC Form 4

Evidence

53
PJ
Portman David J.10% Owner
LONALeonaBio, Inc.
Open-market purchase
BUY$17.33B
5.50M sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC Form 4

Evidence

53
PJ
Portman David J.10% Owner
LONALeonaBio, Inc.
Open-market purchase
BUY$9.92B
3.15M sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC Form 4

Evidence

50
BK
Babcock KenDirector
LBRTLiberty Energy Inc.
Open-market purchase
BUY$223K
14.5K sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC Form 4

Evidence

48
RS
Rosengren Eric SDirector
BBTBeacon Financial Corp
Open-market purchase
BUY$21K
700 sh
Oct 28, 2026Oct 28, 2026
traded Oct 28, 2026
+0dSEC Form 4

Evidence

47
SJ
Schoeman JacobusChief Operating Officer
DRDDRDGOLD LTD
Open-market sale
SELL$231K
94.6K sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC Form 4

Evidence

47
MK
Moloto KgaboGeneral Manager FWGR Ops.
DRDDRDGOLD LTD
Open-market sale
SELL$54K
22.0K sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC Form 4

Evidence

47
KK
Kruger KevinHead of Technical Services
DRDDRDGOLD LTD
Open-market sale
SELL$180K
73.8K sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC Form 4

Evidence

47
GH
Gouws HenryHead of Prod., Dir. of Ergo
DRDDRDGOLD LTD
Open-market sale
SELL$218K
89.2K sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC Form 4

Evidence

47
LD
Lindecke DeanGeneral Manager Ergo Ops.
DRDDRDGOLD LTD
Open-market sale
SELL$119K
48.9K sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC Form 4

Evidence

46
MP
Martins Izilda PChief Financial Officer
SYMSymbotic Inc.
Open-market sale
SELL$281K
7,224 sh
Oct 28, 2026Oct 28, 2026
traded Oct 28, 2026
+0dSEC Form 4

Evidence

46
BE
Burwig Susan EExec. VP, Operations
MEDPMedpace Holdings, Inc.
Open-market sale
SELL$10.87M
16.1K sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC Form 4

Evidence